Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biocane is an Australian pharmaceutical company specializing in the medicinal cannabis sector. The company focuses on the cultivation, production, and distribution of standardized, pharmaceutical-grade cannabis products, including oils and dried flowers. Biocane operates under the regulatory oversight of the Australian Office of Drug Control and the Therapeutic Goods Administration (TGA), ensuring that its products meet strict quality and safety standards for patient use. The company's therapeutic focus is primarily on addressing unmet needs in chronic pain management, neurology, and palliative care through evidence-based cannabinoid therapies. By leveraging local cultivation and advanced extraction techniques, Biocane aims to provide reliable therapeutic options for patients within the growing global medical cannabis market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biocane.